Sarepta Therapeutics Stocks List
Symbol | Grade | Name | Weight | |
---|---|---|---|---|
PINK | C | Simplify Health Care ETF | 8.61 | |
IDNA | D | iShares Genomics Immunology and Healthcare ETF | 5.35 | |
IBRN | D | iShares Neuroscience and Healthcare ETF | 4.27 | |
GNOM | F | Global X Genomics & Biotechnology ETF | 3.99 | |
BBP | D | BioShares Biotechnology Products Fund | 2.58 |
Compare ETFs
Date | Stock | Title |
---|---|---|
Apr 24 | SRPT | Sarepta Therapeutics to Announce First Quarter 2024 Financial Results |
Related Industries:
Biotechnology
- Sarepta Therapeutics
Sarepta Therapeutics, Inc. (NASDAQ: SRPT) is a medical research and drug development company with corporate offices and research facilities in Cambridge, Massachusetts, United States. Incorporated in 1980 as AntiVirals, shortly before going public the company changed its name from AntiVirals to AVI BioPharma soon with stock symbol AVII and in July 2012 changed name from AVI BioPharma to Sarepta Therapeutics and SRPT respectively. As of the end of 2019, the company has two approved drugs (see the Products section below).
Popular Now
Recent Comments
- TraderMike on IZM
- SuccessfulGerbil321 on IZM
- TraderMike on IZM
- TraderMike on Today's Outage
- Crunching_The_Market on Today's Outage
From the Blog
Featured Articles